← Back to Search

N/A

Citicoline supplement for Healthy Subjects

N/A
Waitlist Available
Led By Kathleen Kelley, MD
Research Sponsored by Kirin Holdings Company, Limited
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial is testing whether citicoline, a supplement sometimes taken for cognitive enhancement, actually improves attention and cognition in healthy people compared to a placebo.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Composite score calculated based on scores from the Computerized Mental Performance Assessment System (COMPASS, Northumbria University, Newcastle upon Tyne, UK) that measure cognitive assessment
Secondary outcome measures
Standardized scores on the Computerized Mental Performance Assessment System (COMPASS, Northumbria University, Newcastle upon Tyne, UK) that measure cognitive assessment

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Cognizin®Experimental Treatment1 Intervention
Intervention: Dietary Supplement: Citicoline supplement
Group II: PlaceboPlacebo Group1 Intervention
Intervention: Dietary Supplement: Placebo supplement
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Citicoline supplement
2018
N/A
~310

Find a Location

Who is running the clinical trial?

Kirin Holdings Company, LimitedLead Sponsor
2 Previous Clinical Trials
109 Total Patients Enrolled
Biofortis Clinical Research, Inc.Industry Sponsor
11 Previous Clinical Trials
950 Total Patients Enrolled
Kathleen Kelley, MDPrincipal InvestigatorBiofortis Clinical Research, Inc. Addison, Illinois, United States, 60101
6 Previous Clinical Trials
559 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment accept participants of legal age?

"As outlined in the inclusion criteria, this clinical trial has a lower-age limit of 35 years and an upper-age boundary of 75."

Answered by AI

How many participants can the study accommodate in total?

"Affirmative. Clinicaltrials.gov data clearly states that this study, which was published on 8 September 2021, is still recruiting participants to fill out its 148-person roster at a single site."

Answered by AI

Are there any open spots remaining in this clinical study?

"Affirmative, the information from clinicaltrials.gov affirms that this trial is actively recruiting participants. The study was first uploaded on 8th September 2021 and recently revised on 12th September 2021. This research seeks to enroll 148 volunteers at a single medical centre."

Answered by AI

Could I be considered a participant in this research project?

"This trial is welcoming 148 individuals, aged 35 to 75 years old and deemed a healthy subject (hs), who meet the following requirements: Can comprehend study procedures, has given their informed consent for participation in this research, scores more than 24 on the MMSE, less than 15 on the CESD-R and below 81.25 or above 36.8 on Gradual CPT; additionally self-reports poor attention with no health conditions blocking them from fulfilling all of these criteria as indicated by medical history and regular lab test results."

Answered by AI

Who else is applying?

What state do they live in?
Michigan
Illinois
Florida
How old are they?
18 - 65
What site did they apply to?
Biofortis Clinical Research, Inc.
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

Sounded interesting and I'd like to do some clinical trials.
PatientReceived 1 prior treatment
~41 spots leftby Apr 2025